MAXIMUS announces the acquisition of Canadian-based DeltaWare Systems

MAXIMUS (NYSE: MMS), a leading provider of government services, announced today that it has acquired Canadian-based DeltaWare Systems, Inc. (DeltaWare), a premier developer of health administration management systems for the government health care market. Terms of the transaction were not disclosed.

“MAXIMUS is currently deploying DeltaWare’s Medigent product suite in British Columbia to administer the province’s enrollment system. The addition of this capability will significantly improve our cross-selling opportunities into new markets.”

Medigent^®, DeltaWare’s cornerstone eHealth software, offers a fully integrated suite of eHealth products that can be used independently or in combination to offer advanced electronic healthcare solutions. Medigent enables the exchange and management of electronic medical and health records, including pharmacy, medical, vital statistics, medical travel, dental and drug claims adjudication, extended benefits, and Drug Information System (DIS). The Medigent solution delivers efficiencies and cost savings in the overall health delivery system, and gives government clients flexibility in selecting their delivery model, from turnkey license to program-level business process outsourcing (BPO).

The platform is deployed in nine of Canada’s provinces and territories, including British Columbia, where MAXIMUS and DeltaWare are partners on the Province’s enrollment system upgrade. DeltaWare’s core systems adhere to the emerging medical standards in both Canada and the United States, with the Medigent DIS being the first to implement the new pan-Canadian clinical messaging standard (HL7v3) in an operational setting. DeltaWare is a Canada Health Infoway (CHI) preferred DIS provider and its implementations are assuredly fundable by CHI.

The acquisition is part of the Company’s long-term strategy to broaden its core health services offerings by expanding its BPO capabilities in the emerging eHealth, DIS, and third party claims administration markets in North America and abroad. With this acquisition, MAXIMUS will further strengthen its leading position in the administration of public health programs and extend its capabilities into important adjacent markets.

“DeltaWare and MAXIMUS have enjoyed a rewarding relationship in British Columbia, and their products complement our core health and human services offerings,” commented MAXIMUS CEO Richard A. Montoni. “MAXIMUS is currently deploying DeltaWare’s Medigent product suite in British Columbia to administer the province’s enrollment system. The addition of this capability will significantly improve our cross-selling opportunities into new markets.”